Multimodal polymeric contrast agents for MRI and fluorescence imaging in the management of cancer
The multimodal polymeric contrast agents for MRI and fluorescence imaging in the management of cancer are discussed. The paper presents preliminary data that suggest that a simple experimental protocol can provide at least an index of the permeability parameter if not the absolute permeability itself.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.